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Peroxisome proliferator activated receptors: 
transcriptional regulators of adipogenesis, 
lipid metabolism and more... 
The recent discovery of lipid-activatable transcription factors that regulate the genes 
controlling lipid metabolism and adipogenesis has provided insight into the 
way that organisms sense and respond to lipid levels. Identification of 
the signaling pathways in which these receptors are involved will 
help us to understand the control of energy balance and 
the molecular defects underlying its disorders. 
Chemistry & Biology May 1995, 2:261-266 
Free-living cells like bacteria are often exposed to dramatic 
changes of their environment. They adapt to variations in 
their surroundings through inducible enzyme systems that 
respond to environmental signals, which often correspond 
to nutritional stress. Bacteria and lower eukaryotes invoke 
such systems to make use of nitrate and phosphate, meta- 
bolize sugars and synthesize amino acids and nucleotides. 
In higher eukaryotes such as vertebrates, most cells of the 
organism are not exposed to strong environmental fluctua- 
tions. Exceptions to this rule include the epidermis, the 
digestive tract mucosa and the liver, which receives its 
blood supply directly from the gut via the large portal 
vein. Hepatocytes are therefore exposed to qualitative and 
quantitative changes in the supply of nutrients, and some- 
times to toxic compounds taken up with food. If the 
animal ingests a carbohydrate-rich low-fat diet, the pres- 
ence of glucose activates the transcription of glycolytic and 
lipogenic genes in the liver. A low-carbohydrate diet, in 
contrast, induces gluconeogenic enzymes that convert 
amino acids into glucose, as well as enzymes from the 
lipolytic pathway which release energy stored as trigly- 
cerides [l], while a high-fat diet stimulates genes involved 
in lipid storage and expenditure [2]. Thus, there must be 
factors that regulate fuel selection according to the 
availability of glucose and lipid, and govern their 
interconversion, transport, storage, mobilization and use. 
Obviously, regulation must operate on several metabolic 
pathways to ensure a healthy energy homeostasis. Obesity 
is one of the disorders of this balance; it is often associated 
with type II diabetes, hypertension and atherosclerosis. So 
far, little is known about the proteins that mediate the 
nutritional signals for gene control.The recent discovery 
of the peroxisome proliferator activated receptors 
(PPARs), a family of lipid-activable transcription factors, 
thus represents a breakthrough in the molecular 
understanding of lipid homeostasis [3-61. 
PPAR structure, distribution and activation 
PPARs are members of the nuclear hormone receptor 
superfamily and are relatives of the steroid, thyroid and 
retinoid hormone receptors [7]. All members of this super- 
family share a characteristic organization of their structural 
and functional domains (see Fig. la). PPARs are activated 
by a diverse group of substances called the peroxisome 
proliferators, which induce massive proliferation of peroxi- 
somes in rodent hepatocytes. The group includes fibrate 
hypolipidemic drugs such as clofibrate (see Fig. lb) as well 
as certain plasticizers and herbicides. The nature of the 
molecular mechanism by which these various amphipathic 
carboxylates activate PPARs is still unclear. 
PPARs form a distinct subfamily within the superfamily 
of nuclear hormone receptors, with at least three gene 
loci in all the species thus far studied.These are OL, B and 
y in Xenopus laevis [4], (Y, 6 and y in mouse [8] and o, 
NUC-1 and y in man [7,9,10]. Evolutionary analyses 
show that the (Y and y loci in different species are 
homologous, but it is not clear whether the Xenopus B 
gene is the homolog of the mouse 6 and human NUC-1 
genes [7]. In Xeno~~, PPARor and B are expressed in 
oocytes and early embryos, whereas in rodents it is 
PPARS that is present at early stages [4,8]. In adults of all 
species tested, the PPARol gene is highly expressed in 
tissues with high lipid metabolism (liver, kidney, white 
and brown adipose tissues) and is transcriptionally regu- 
lated by glucocorticoids in liver [3,4,8,11]. PPARB 
(Xenopus) or 6 (rodents) app ears to be expressed ubiqui- 
tously, albeit at a low level in liver. PPARy is observed at 
a high level in white adipose tissue and spleen of rodents 
[8,12] and in fat bodies of Xenopus [4]. 
Although PPARs were named by virtue of their activa- 
tion by peroxisome proliferators, the finding that natural 
fatty acids (such as linoleic acid; see Fig. lb) activate 
them as well raises the question of whether fatty acids are 
the true ligands. If so, this would suggest that nutrient 
derivatives can act on gene regulation in the same way as 
steroid or thyroid hormones. So far, it appears that no’ 
one fatty acid exclusively activates a given PPAR subtype 
[5,6,13]. Fatty acids with a chain length of 10 or more 
carbons activate PPARs from several species, while those 
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with shorter chains are much less active.With the excep- 
tion of Xenopus PPARor, which has a preference for 
polyunsaturated fatty acids rather than mono-unsaturated 
or saturated fatty acids, the position (o-3 versus o-6) or 
number of unsaturated bonds appear to have no major 
effects. Interestingly, o-3 fatty acids, like hypolipidemic 
drugs, lower serum lipid concentrations, suggesting that 
they may preferentially activate a PPAR subtype that is 
involved in controlling lipid uptake or breakdown. 
Although it is not yet clear to what extent PPAR sub- 
types can be specifically activated by different fatty acids, 
they are distinct with respect to their activation by 
various synthetic or natural compounds. Pirinixic acid 
(Wy14,643), an experimental hypolipidemic drug, is a 
potent activator of mouse PPARcx but not of PPARG and 
y [8]. Similarly, the arachidonic acid analog ETYA, so far 
the most potent activator of Xenopus PPARcY, does not 
activate PPARB and y [13]. Significant activation of 
Fig. 1. Peroxisome proliferator activated 
receptors (PPARs) and PPAR activators. 
(a) PPARs are organized into six struc- 
tural and functional domains (A-F), like 
the steroid hormone receptors. The 
main functions of domains A/B, C and E 
are indicated. The DNA-binding domain 
C is characterized by two zinc fingers of 
the C4 subtype. The P box in the first 
finger is responsible for specific recog- 
nition of the response element.and the 
D box in the second finger, characteris- 
tically containing only three amino- 
acids in PPARs, is involved in 
dimerization. PPARs regulate transcrip- 
tion of their target genes by hetero- 
dimerization with the 9-cis retinoic acid 
receptor, also called the retinoid X 
receptor (RXR). In the promoter region 
of target genes, the PPAR/RXR het- 
erodimer binds to a specific peroxisome 
proliferator response element, which is 
a direct repeat of the AGGTCA motif 
with one nucleotide spacing. (b) PPAR 
activators. PPARs are activated by long 
chain fatty acids (natural fatty acids 
such as linoleic acid), peroxisome pro- 
liferators (including hypolipidemic 
drugs such as clofibrate), and thiazo- 
lidinediones such as BRL 49653 (an 
antidiabetic agent). 
- 
mouse PPARy is obtained with the leukotriene anta- 
gonist LY-171883 and, more interestingly, with an antidia- 
betic thiazolidinedione (BRL49653; see Fig. lb), which 
binds to this subtype with a K, of 40 nM [14]. For mouse 
PPARG, the most potent activator known is linoleic acid 
[S]. The PPAR subtyp es may therefore respond differen- 
tially to various physiological activators as well. Together 
with the varying expression of the receptor subtypes, such 
differential regulation would allow this receptor family to 
fulfill a number of distinct functions during development 
and in adulthood. 
Dimerization is essential for the function of most of the 
members of the hormone receptor superfamily. This holds 
also for the PPARs; they heterodimerize with the 9-cir 
retinoic acid receptor (R2CEQ, forming a complex that can 
stimulate gene activity. The dimer of PPAR and RXR 
binds to a hormone-response element located in the pro- 
moter region of target genes. This element comprises a 
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direct repeat of the AGGTCA motif with a one- 
nucleotide spacer between the two half-sites (Fig. la) 
[5,15]. The physiological consequences of this conver- 
gence between the signaling pathways of fatty acids and 
retinoids through PPAR/RXR heterodimers remain to 
be elucidated. It is clear from the involvement of RXR in 
the action of PPAR that there must be some crosstalk 
with the receptors for thyroid hormone, all-tvuns retinoic 
acid and vitamin D, which all also have RXR as a partner. 
There is, of course, ample evidence that retinoids, thyroid 
hormones and vitamin D are important in development 
and cell differentiation. So far, however, there is little evi- 
dence for a function of PPARs in cellular differentiation, 
with the exception of their involvement in adipogenesis 
[16,17] and possibly in the formation of the lipid barrier 
in the epidermis [18]. 
Role of PPAR in adipogenesis 
Adipocytes are of central importance in lipid storage and 
in the regulation of energy balance.They store energy in 
the form of triglycerides when food availability is high 
and release it in the form of free fatty acids under condi- 
tions of energy expenditure [19]. The expansion of 
adipose tissue mass when excess food is ingested requires 
differentiation of adipocytes from precursor cells. If the 
signal to differentiate is an elevated level of plasma lipids, 
a direct signal transduction pathway similar to that used 
by lipophilic hormones (steroids, thyroid hormones) can 
be envisaged, in which a lipid-activated transcription 
factor senses the hyperlipidemic state and triggers adipo- 
genesis. Such a pathway would be similar to the one that 
controls the release of the sterol regulatory element 
binding proteins [20]. These transcription factors are 
Table 1. Genes regulated by fatty acids (FA) and peroxisome proliferators (PP). 
Hepatocytes 
FAIPP PPARs References 
1. Extra- and intra-cellular FA transport 
1 .I: L-FABP (liver fatty-acid-binding protein) 
1.2: Apolipoprotein Al 
1.2: Apolopoprotein A II 
1.2: Lipoprotein lipase 
1.2: Apolipoprotein C-III 
1.3: Carnitine-palmitoyl transferase 1 
1.4: Carnitine-acyl transferase 
1.5: Carnitine-octanoyl transferase 
2. Mitochondrial P-oxidation 
Medium chain acyl-CoA dehydrogenase 
3. Peroxisomal P-oxidation 
Acyl-CoA synthetase 
Acyl-CoA oxidase 
Enoyl-CoA hydratase/3-OH-acyl-CoA dehydrogenase 
3-Ketoacyl-CoA thiolase 
4. Microsomal w-oxidation 
P450 4A6 (fatty acid w-hydroxylase) 
5. Ketone body synthesis 
HMG-CoA synthase 
6. Fatty acid synthesis 
Malic enzyme 
Adipocytes 
+ 
+ 
+ 
- 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
-/‘+a 
+ 
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n.d. 
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n.d. 
n.d. 
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+ 
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n.d. 
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[261 
[271 
1281,b 
[291 
[301 
[311 
[311 
t321 
[331 
I41 
[341 
t311 
[351 
[361 
[3 71 
1. Extra- and intra-cellular FA transport 
1 .I : aP2 (adipocyte lipid-binding protein) + + 1121 
1 .I : MAL-1 (keratinocyte-lipid binding protein) + n.d. t221 
7. Glyceroneogenesis 
Phosphoenolpyruvate carboxykinase (PEPCK) + + [381 
Some of the genes (bold) are direct targets of PPARs. FA/PP-regulated genes have been studied mainly in hepatocytes (top) and 
adipocytes (bottom), where they are involved in various lipid metabolic pathways (numbered 1 to 7). Stimulation (+) or repression 
(-) of gene activity either by FNPP or by PPARs is indicated. n.d.: direct regulation by PPARs not yet determined. 
aFibrates down-regulate the transcription of the APO-AI gene independently of PPARs, whereas PPARs can overcome this 
down-regulation via a functional PPRE in the APO-AI promoter. 
bK. Schoonjans, B. Staels, S. Deeb and 1. Auwerx, personal communication. 
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Fig. 2. Main lipid metabolic pathways 
regulated by PPAR target genes. PPARs 
are involved in (1) the regulation of 
fatty acid extra- and intra-cellular trans- 
port, (2) mitochondrial p-oxidation, (3) 
peroxisomal P-oxidation, (4) micro- 
somal w-oxidation, (5) mitochondrial 
ketone body synthesis, (6) fatty acid 
synthesis and (7) glyceroneogenesis. 
The pathways are numbered as in Table 
1. TC, triglycerides; FFA, free fatty 
acids; PL, phospholipids; FABPs, fatty 
acid binding proteins. 
TC \ / FFA 
pyruvate 
I 
I 
@ glyceroneogenesis 
+ 
a 
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glycerol 
Triglycerides 
@ ; FA synthesis 
sensors of sterol levels and are synthesized as membrane- 
bound precursors. They are proteolytically cleaved and 
released as active nuclear factors only in the absence of 
sterols.When sterols overaccumulate in cells as a result of 
high cholesterol diets, precursor cleavage is abolished and 
the expression of target genes, such as the gene for the 
low density lipoprotein receptor, declines. 
The first transcription factor identified as a potential 
regulator of the adipose differentiation process, 
C/EBPa, did not meet the requirements for a lipid 
overload sensor because it does not appear to bind or to 
be activated by fatty acids [21]. Nevertheless, this basic 
leucine zipper transcription factor binds to the promo- 
ters of several genes expressed in adipocytes, and can 
induce the adipogenic program in a variety of fibroblas- 
tic cells. It is thus thought to be involved in adipogene- 
sis control possibly through a combined action with 
PPAR [17]. Indeed, PPARy seems likely to be involved 
in the regulation of adipose cell number in response to 
variations in lipid flux. It is highly expressed in fat 
tissues and it has been recently shown to activate the 
program of adipocyte gene expression and to stimulate 
adipose differentiation of cultured fibroblasts in a 
PPAR-activator-dependent manner [16,17]. Increased 
levels of fatty acids or fatty acid metabolites may acti- 
vate PPARy, in turn stimulating adipogenesis. WEBPa 
cooperates with PPARy to stimulate this differentiation 
program, suggesting that both transcription factors are 
required for the development of adipose cells from 
uncommitted mesodermal precursors [17].These obser- 
vations suggest that it may be possible to develop syn- 
thetic compounds that would bind to PPARy and 
interfere with the regulation of the number of adipose 
cells in the organism. 
Regulation of lipid metabolism 
PPAR subtypes are also expressed in a variety of non- 
adipose tissues, where they are probably also engaged in 
lipid metabolism. So far, however, the identification of 
PPAR target genes has concentrated mainly on hepato- 
cytes and adipocytes, because of their importance in sys- 
temic lipid metabolism. The target genes identified so 
far are summarized in Table 1. These control key func- 
tions of lipid metabolism, such as transport and cellular 
uptake of lipids, intracellular balance between free and 
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bound fatty acids, conversion of fatty acids to their acti- 
vated CoA form, penetration of fatty acids into mem- 
brane-delimited organelles, microsomal w-oxidation, 
peroxisomal P-oxidation, mitochondrial P-oxidation 
and ketogenesis, as well as the production of glycerol for 
triglyceride synthesis. Indeed, essentially all of the major 
pathways of lipid metabolism appear to be under the 
control of one or more PPAR-regulated genes. These 
pathways are often regulated at several levels, allowing 
fine-tuning of the whole network response to a stimulus 
(Fig. 2). Thus, lipids control their own metabolism, 
mainly by controlling transcription of the genes 
involved in it. 
The homeostasis of lipid levels and that of energy levels 
are intimately interlinked and are-regulated by systems 
that are sensitive to many stimuli, including those that are 
environmental (light, temperature), psychological (stress) 
and physical (activity).The responses to these stimuli by 
lipid- and energy-regulating systems is coordinated by the 
brain, mostly through hypothalamic functions. In this 
article, we have addressed only one aspect of this complex 
network, namely the control by lipids of their own 
metabolism. The discovery that fatty acids can activate 
transcription factors, and can therefore regulate many 
cellular and physiologic pathways (see Fig. 2), changes our 
view of lipids from mainly passive to active participants in 
cell differentiation and metabolic regulation. 
PPAR in health and disease: future prospects 
Disorders like obesity, hyperlipidemia, atherosclerosis 
and type II diabetes are often causally linked to each 
other and associated with the dysfunction of genes 
implicated in energy homeostasis in a broad sense. 
Although not all of these will be genes that are directly 
regulated by PPARs, the interdependence of the systems 
that regulate the supply of energy and those that regu- 
late lipid metabolism suggests that manipulation of 
PPAR target genes might have therapeutic benefits. For 
example, fibrate hypolipidemic drugs and thiazolidine- 
diones, a new class of antidiabetic agents that improve 
insulin sensitivity in rodent models of non-insulin- 
dependent diabetes mellitus (NIDDM), appear to act via 
PPARs [3,4,14,22]. However, the link between the acti- 
vation of PPARy by antidiabetics of this class and the 
reduction of plasma glucose, triglyceride and insulin 
levels that these compounds induce remains unclear (see 
[14]). The action of PPARy may regulate endocrine 
functions of the adipose tissue, for instance by modulat- 
ing the production and release of the product of the ob 
gene, which is mutant in obese mice [23], and ofTNFol, 
which affects insulin signaling [24]. The discovery of 
new PPAR-subtype-specific agonists or antagonists 
should prove very valuable for a better understanding of 
the signaling cascade of each subtype, and will help us 
understand how lipid and energy levels are controlled 
during normal development and in adulthood. There is 
no doubt that further investigations on PPARs will 
provide answers to some of the long-standing questions 
regarding the contribution of adipogenesis and lipid 
metabolism to energy balance and the molecular defects 
underlying its disorders. 
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